510(k) Report

510(k) · Cleared

Cleared

Inomax DS (Delivery System)

K081691510(k) SpecialCleared Aug 28, 200872-day reviewClass II21 CFR 868.5165

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ino Therapeutics, LLC · MRN Apparatus, Nitric Oxide Delivery

Cleared on Aug 28, 2008 as substantially equivalent to K061901 (Ino Therapeutics, 2006) and 2 other predicates after a 72-day review. Its family tree reaches back 6 generations to 2001. 11 later devices descend from it.

Decided
Aug 28, 2008
Review
72 days
Class
Class II
Product code
MRN
Recalls
None
Predicates
4

Its longest line of descent runs back 6 generations to K003665 (2001). 9 ancestors in all, the oldest K000186 (2000). 11 later devices descend from it, 6 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2003: 1 other ancestor2000: 2 other ancestors2011: 2 descendants cleared2012: 2 descendants cleared2013: 2 descendants cleared2015: 1 descendant cleared2023: 2 descendants cleared2020: 1 descendant cleared2025: 1 descendant clearedK003665 · Fadassi Medical FM-1 NO Blender · Fadasis Medical, Inc. · 2001K011874 · Fadasis Medical FM-1 NO Blender · Fadasis Medical, Inc. · 2001K052663 · Ino Therapeutics Inoblender, Model 10004 · Ino Therapeutics · 2005K061901 · Ino Therapeutics Inomax DS (Delivery System), Model 10003 · Ino Therapeutics · 2006 · recalledK070867 · Inomax DS (Delivery System), Model 10003 · Ino Therapeutics, LLC · 2007K071516 · Inomax DS · Ino Therapeutics, LLC · 2007200020052010201520202025
  1. Root · 6 generations backK003665 Fadassi Medical FM-1 NO BlenderFadasis Medical, Inc. · 2001
  2. 5 generations backK011874 Fadasis Medical FM-1 NO BlenderFadasis Medical, Inc. · 2001
  3. 4 generations backK052663 Ino Therapeutics Inoblender, Model 10004Ino Therapeutics · 2005
  4. 3 generations backK061901 Ino Therapeutics Inomax DS (Delivery System), Model 10003Ino Therapeutics · 2006 · Recalled
  5. 2 generations backK070867 Inomax DS (Delivery System), Model 10003Ino Therapeutics, LLC · 2007
  6. 1 generation backK071516 Inomax DSIno Therapeutics, LLC · 2007
  7. This deviceK081691 Inomax DS (Delivery System)Ino Therapeutics, LLC · 2008
  8. Descendant · cites it directly · 9 of its ownK110344 Inomax Dsir (Delivery System)Ino Therapeutics · 2011
  9. Descendant · cites it directly · 9 of its ownK110635 Inomax DS (IR) (Delivery System)Ino Therapeutics, LLC/Dba Ikaria · 2011
  10. Descendant · cites it directly · 8 of its ownK113272 Inomax DS (Delivery SystemsIno Therapeutics, LLC/Dba Ikaria · 2012
  11. Descendant · cites it directly · 7 of its ownK121021 Inomax DS (Delivery System)Ino Therapeutics · 2012
  12. Descendant · cites it directly · 6 of its ownK130605 Inomax Dsir (Delivery System)Ino Therapeutics · 2013

Showing 5 of 11 descendants. See all descendants

Descendants cleared per year

2011: 22012: 22013: 22015: 12020: 12023: 22025: 1
2011high 2 (2011) · low 0 (2014)2026

Most influential descendants

Showing 5 of 11 · See all
  • K110344Inomax Dsir (Delivery System)Ino Therapeutics · 2011 · cites it directly9descendants
  • K110635Inomax DS (IR) (Delivery System)Ino Therapeutics, LLC/Dba Ikaria · 2011 · cites it directly9descendants
  • K113272Inomax DS (Delivery SystemsIno Therapeutics, LLC/Dba Ikaria · 2012 · cites it directly8descendants
  • K121021Inomax DS (Delivery System)Ino Therapeutics · 2012 · cites it directly7descendants
  • K130605Inomax Dsir (Delivery System)Ino Therapeutics · 2013 · cites it directly6descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K003665Fadassi Medical FM-1 NO BlenderFadasis Medical, Inc.2001—
−5K011874Fadasis Medical FM-1 NO BlenderFadasis Medical, Inc.2001—
−4K052663Ino Therapeutics Inoblender, Model 10004Ino Therapeutics2005—
−3K061901Ino Therapeutics Inomax DS (Delivery System), Model 10003Ino Therapeutics20063
−2K070867Inomax DS (Delivery System), Model 10003Ino Therapeutics, LLC2007—
−1K071516Inomax DSIno Therapeutics, LLC2007—
0 (this device)K081691Inomax DS (Delivery System)Ino Therapeutics, LLC2008—
+1K110344Inomax Dsir (Delivery System)Ino Therapeutics2011—
+1K110635Inomax DS (IR) (Delivery System)Ino Therapeutics, LLC/Dba Ikaria2011—
+1K113272Inomax DS (Delivery SystemsIno Therapeutics, LLC/Dba Ikaria2012—
+1K121021Inomax DS (Delivery System)Ino Therapeutics2012—
+1K130605Inomax Dsir (Delivery System)Ino Therapeutics2013—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200020
200310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201120
201220
201320
201510
202010
202320
202510
FIG. 1 — Lineage of K081691, 2001–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MRN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MRN device

  1. #1 K242374 ULSPIRA TS™ Nitric Oxide Therapy Systemscore 12.6 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.

TypeNumberDeviceApplicantDecidedRecalls
*K061901Ino Therapeutics Inomax DS (Delivery System), Model 10003
Summary page 1
…l: Anesthesiology Predicate Device(s): INO Therapeutics' INOmax TM DS (Delivery System) (primary) 510(k) Number K061901 INO Therapeutics' INOmax DS (Delivery System) 510(k) Numb…
Ino Therapeutics20063
*K070867Inomax DS (Delivery System), Model 10003
Summary page 1
…(primary) 510(k) Number K061901 INO Therapeutics' INOmax DS (Delivery System) 510(k) Number K070867 INO Therapeutics' INOmax DS (Delivery System) 510(k) Numb…
Ino Therapeutics, LLC2007—
*K071516Inomax DS
Summary page 1
…510(k) Number K070867 INO Therapeutics' INOmax DS (Delivery System) 510(k) Number K071516 Datex-Ohmeda INOvent Delivery System (now GE Healthcare) 510(k) Numbe…
Ino Therapeutics, LLC2007—
Kept off the family treeK974562Datex-Ohmeda INOvent Delivery System (now GE Healthcare)
Not in FDA’s 510(k), De Novo or PMA lists as we hold them (a misreading, a typo, or a number FDA does not list), so it is kept off the family tree
Summary page 1
…510(k) Number K071516 Datex-Ohmeda INOvent Delivery System (now GE Healthcare) 510(k) Number K974562 Contact Person: David M. Trueblood, Director, Regulatory Affairs Patient Population: The targeted patient population is…

Also cleared against K061901: 13 other devices →

What descends from it? (11)

See all 11

6 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K110344Inomax Dsir (Delivery System)Ino Therapeutics20119
K110635Inomax DS (IR) (Delivery System)Ino Therapeutics, LLC/Dba Ikaria20119
K113272Inomax DS (Delivery SystemsIno Therapeutics, LLC/Dba Ikaria20128
K121021Inomax DS (Delivery System)Ino Therapeutics20127
K130605Inomax Dsir (Delivery System)Ino Therapeutics20136
K131686Inomax Dsir (Delivery System)Ino Therapeutics/Ikaria20135

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 3 companies; a new generation was cleared every 11 months on median.
  • 2 of the 9 ancestors have a recall of any class.
  • Of its descendants, K110344 (Ino Therapeutics, 2011) has gone furthest, with 9 descendants of its own.
  • 13 other devices also cite its predicate K061901.

How does its category compare?

All MRN devices

MRN Apparatus, Nitric Oxide Delivery: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · MRN

2in 2025

2007: 22008: 22009: 12010: 22011: 22012: 32013: 22015: 12018: 12020: 32022: 12023: 42024: 22025: 2
2007high 4 (2023) · low 0 (2014)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MRN

566in 2023

2012: 117 days median2020: 84 days median2023: 566 days median
2007high 566 (2023) · low 84 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MRN

2in 2025

2010: 22014: 12023: 12025: 2, 2 Class I2026 (partial year): 2
2007high 2 (2010) · low 0 (2007)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · MRN

155in 2025

2007: 32008: 92009: 102010: 1552011: 552012: 242013: 322014: 792015: 1562016: 942017: 1062018: 1382019: 1442020: 1992021: 2212022: 1152023: 992024: 1382025: 155
2007high 221 (2021) · low 3 (2007)2025

MAUDE reports naming product code MRN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—03
20082—09
20091—010
20102—2155
20112—055
20123117024
20132—032
20140—179
20151—0156
20160—094
20170—0106
20181—0138
20190—0144
20203840199
20210—0221
20221—0115
20234566199
20242—0138
20252—2 (2)155
20260—2—

What is it indicated for?

The INOmax DS delivery system delivers INOmax® (nitric oxide of inhalation) therapy gas into the inspiratory limb of the patient breathing circuit in a way that provides a constant concentration of nitric oxide (NO), as set by the user, to the patient throughout the inspired breath. It uses a specially designed injector module, which enables tracking of the ventilator waveforms and the delivery of a synchronized and proportional dose of NO. It may be…

Read the full statement (207 words)

The INOmax DS delivery system delivers INOmax® (nitric oxide of inhalation) therapy gas into the inspiratory limb of the patient breathing circuit in a way that provides a constant concentration of nitric oxide (NO), as set by the user, to the patient throughout the inspired breath. It uses a specially designed injector module, which enables tracking of the ventilator waveforms and the delivery of a synchronized and proportional dose of NO. It may be used with most ventilators.

The INOmax DS provides continuous integrated monitoring of inspired 02, NO 2, and NO, and a comprehensive alarm system.

The INOmax DS incorporates a battery that provides up to 6 hours of uninterrupted NO delivery in the absence of an external power source.

The INOmax DS includes a backup NO delivery capability that provides a fixed flow of 250 mL/min of NO which along with user supplied 10 L/min of oxygen provides 20 ppm in the gas flow to a patients breathing circuit. It may also use the INOblender for backup.

The target patient population is controlled by the drug labeling for INOmax and is currently neonates. The primary targeted clinical setting is the Neonatal Intensive Care Unit (NICU) and secondary targeted clinical setting is the transport of neonates.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K081691: Inomax DS (Delivery System).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K081691

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026